James Mcnab, Director at Curis, holds 52.69K shares in Titan Pharmaceuticals (Ticker: TTNP), holds 1.35M shares in Curis (Ticker: CRIS), holds 551.82K shares in Echo Therapeutics (Ticker: ECTE).
What is the percentage of profitable transactions made by James Mcnab?
The percentage of profitable transactions made by James Mcnab is 33%.
What is the average return per transaction made by James Mcnab?
The average return per transaction made by James Mcnab is -38.10%.
What stocks does James Mcnab hold?
James Mcnab holds: CRIS, TTNP, ECTE stocks.
What was James Mcnab’s latest transaction?
James Mcnab latest transaction was an Uninformative Buy of ―.
What was James Mcnab's most profitable transaction?
James Mcnab’s most profitable transaction was an Informative Buy of TTNP stock on January 13, 2016. The return on the trade was 29.00%.
What is James Mcnab's role in Curis?
James Mcnab's role in Curis is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.